Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?
Marren SM, Hammersley S, McDonald TJ, Shields BM, Knight BA, Hill A, Bolt R, Tree TI, Roep BO, Hattersley AT, Jones AG, Oram RA; TIGI consortium. Marren SM, et al. Among authors: jones ag. Diabet Med. 2019 Sep;36(9):1092-1099. doi: 10.1111/dme.13960. Epub 2019 Jun 27. Diabet Med. 2019. PMID: 30955221 Free PMC article.
The challenge of diagnosing type 1 diabetes in older adults.
Jones AG, Shields BM, Dennis JM, Hattersley AT, McDonald TJ, Thomas NJ. Jones AG, et al. Diabet Med. 2020 Oct;37(10):1781-1782. doi: 10.1111/dme.14272. Epub 2020 Feb 24. Diabet Med. 2020. PMID: 32043618 No abstract available.
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87).
Agbaje OF, Coleman RL, Hattersley AT, Jones AG, Pearson ER, Shields BM, Holman RR; MASTERMIND consortium. Agbaje OF, et al. Among authors: jones ag. Diabetes Res Clin Pract. 2020 Aug;166:108333. doi: 10.1016/j.diabres.2020.108333. Epub 2020 Jul 21. Diabetes Res Clin Pract. 2020. PMID: 32702468 Clinical Trial.
HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study.
Niwaha AJ, Rodgers LR, Greiner R, Balungi PA, Mwebaze R, McDonald TJ, Hattersley AT, Shields BM, Nyirenda MJ, Jones AG. Niwaha AJ, et al. Among authors: jones ag. BMJ Open Diabetes Res Care. 2021 Sep;9(1):e002350. doi: 10.1136/bmjdrc-2021-002350. BMJ Open Diabetes Res Care. 2021. PMID: 34535465 Free PMC article.
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study.
Niwaha AJ, Rodgers LR, Carr ALJ, Balungi PA, Mwebaze R, Hattersley AT, Shields BM, Nyirenda MJ, Jones AG. Niwaha AJ, et al. Among authors: jones ag. BMJ Open Diabetes Res Care. 2022 Apr;10(2):e002714. doi: 10.1136/bmjdrc-2021-002714. BMJ Open Diabetes Res Care. 2022. PMID: 35450869 Free PMC article.
Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study.
Shields BM, Dennis JM, Angwin CD, Warren F, Henley WE, Farmer AJ, Sattar N, Holman RR, Jones AG, Pearson ER, Hattersley AT; TriMaster Study group. Shields BM, et al. Among authors: jones ag. Nat Med. 2023 Feb;29(2):376-383. doi: 10.1038/s41591-022-02120-7. Epub 2022 Dec 7. Nat Med. 2023. PMID: 36477733 Free PMC article. Clinical Trial.
364 results